Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2

被引:3
|
作者
Temel, Jennifer S.
Currow, David Christopher
Fearon, Kenneth
Yan, Ying
Friend, John
Abernethy, Amy Pickar
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Helsinn Therapeut Inc, Iselin, NJ USA
[5] Duke Univ, Durham, NC USA
关键词
D O I
10.1200/jco.2015.33.29_suppl.175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
175
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies
    Surmont, V.
    Smit, E. F.
    de Jonge, M.
    Aerts, J. G.
    Nackaerts, K.
    Vernhout, R.
    Gras, J.
    Van Wijk, A.
    Phernambucq, E. C. J.
    van Meerbeeck, J. P.
    Senan, S.
    Kraaij, C. J.
    Chouaki, N.
    Praag, J.
    van Klaveren, R. J.
    LUNG CANCER, 2010, 69 (03) : 302 - 306
  • [42] ONO-7643/Anamorelin for the Treatment of Cancer Cachexia in Advanced NSCLC Patients: Results From the Phase 2 Study in Japan
    Katakami, Nobuyuki
    Yokoyama, Takuma
    Atagi, Shinji
    Yoshimori, Kouzou
    Kagamu, Hiroshi
    Takeda, Yuichiro
    Takase, Keiichirou
    Saito, Hiroshi
    Eguchi, Kenji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S229 - S229
  • [43] Cachexia Index utilization in patients with non-small cell lung cancer.
    Rybar, Douglas William
    Ng, Ronald
    Fidler, Mary J.
    Kerns, Samantha
    Sayidine, Selina
    Basu, Sanjib
    Borgia, Jeffrey Allen
    Dudek, Arkadiusz Z.
    Bonomi, Philip
    Shah, Palmi
    Menchaca, Martha
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Anamorelin for the treatment of cancer anorexia-cachexia: Baseline characteristics from three phase III clinical trials (the ROMANA program)
    Abernethy, Amy Pickar
    Currow, David
    Fearon, Kenneth
    Gleich, Lyon L.
    Friend, John
    Temel, Jennifer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] RESULTS FROM A PILOT EDUCATIONAL NEEDS ASSESSMENT SURVEY ON CANCER ANOREXIA-CACHEXIA SYNDROME (CACS) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Duus, Elizabeth
    Williams, Mark
    Matthews, Cassandra
    Friend, John
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E77 - E77
  • [46] Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results
    Gentzler, R. D.
    Mohindra, N. A.
    Hanna, N.
    Chae, Y. K.
    Jalal, S. I.
    Hall, R.
    Villaflor, V. M.
    Reckamp, K. L.
    Koczywas, M.
    Sullivan, D.
    Wood, L.
    Patel, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 236 - 236
  • [47] Unecritinib in Patients with ROS1 Positive Advanced Non-Small Cell Lung Cancer: Updated Results from a Phase II Trial
    Lu, S.
    Pan, H.
    Wu, L.
    Yao, Y.
    He, J.
    Wang, Y.
    Wang, X.
    Fang, Y.
    Zhou, Z.
    Wang, X.
    Cai, X.
    Yu, Y.
    Ma, Z.
    Min, X.
    Yang, Z.
    Cao, L.
    Yang, H.
    Shu, Y.
    Zhuang, W.
    Cang, S.
    Fang, J.
    Li, K.
    Yu, Z.
    Cui, J.
    Zhang, Y.
    Li, M.
    Wen, X.
    Zhang, J.
    Li, W.
    Shi, J.
    Xu, X.
    Zhong, D.
    Li, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S73 - S74
  • [48] Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
    Ou, Sai-Hong Ignatius
    Govindan, Ramaswamy
    Eaton, Keith D.
    Otterson, Gregory A.
    Gutierrez, Martin E.
    Mita, Alain C.
    Argiris, Athanassios
    Brega, Nicoletta M.
    Usari, Tiziana
    Tan, Weiwei
    Ho, Steffan N.
    Robert, Francisco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : 145 - 151
  • [49] Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer
    Fujii, Hironori
    Araki, Ayumu
    Iihara, Hirotoshi
    Kaito, Daizo
    Hirose, Chiemi
    Kinomura, Motohiko
    Yamazaki, Mizuki
    Endo, Junki
    Inui, Toshiya
    Yanase, Komei
    Sasaki, Yuka
    Gomyo, Takenobu
    Sakai, Chizuru
    Kawae, Daisuke
    Kitamura, Yu
    Fukui, Masachika
    Kobayashi, Ryo
    Ohno, Yasushi
    Suzuki, Akio
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [50] Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Yasenchak, C.
    Nackaerts, K.
    Awada, A.
    Gadgeel, S. M.
    Hellerstedt, B.
    Perry, M. C.
    Richards, D.
    Yang, C. H.
    Scheffold, C.
    Lara, P. N., Jr.
    EJC SUPPLEMENTS, 2010, 8 (07): : 126 - 126